Home » Newsletters » BioWorld

BioWorld

Aug. 10, 1993

View Archived Issues

REPLIGEN'S AM285 INHIBITS TUMORS

ZYNAXIS SEEKS MARKETING APPROVAL

SKB, IGI TO JOINTLY TEST VACCINE

REGENERON REPORTS PHASE II RESULTS

NOVEL GENE DEFECT FOUND FOR DMD

CEPHALON RAISES $3 MILLION

FDA PANEL RECOMMENDS PULMOZYME

DYNAGEN COMPLETES REGULATION S FINANCING

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...